Malaria treatment policies and drug efficacy in Haiti from 1955-2012

Table 1 Reports of treatment efficacy for malaria in Haiti

Period	Sample size	Site in Haiti	Drug combination	Source of data used	Resistant	Susceptible	Reference
1960-1966	N/A	Country Wide	CQ/P	Secondary	N/A	CQ	PAHO. 1967 [14]
1961	N/A	Country Wide	CQ	Secondary	N/A	CQ	WHO. 1965 [13]
1962-1965	N/A	Country Wide	CQ/P	Secondary	N/A	CQ/P	Mason J and Philippe A, 1967 [12]
1962-1965	N/A	Petitie Goave	CQ & CQ/P	Secondary	N/A	CQ/P	WHO, 1968 [15]
1971	N/A	Country Wide	CQ	Secondary	VV, P & CG	CQ	WHO, 1972 [16]
1976	N/A	Country Wide	N/A	Secondary	N/A	CQ	WHO, 1978 [17]
1980	N/A	Country Wide	CQ	Secondary	N/A	VV CQ	PAHO, 1980 [9]
1981-1983	92	Les Cayes, Port-au-Prince, Limbe, Gros-Morne and Jacmel	CQ	Secondary	VT & VV CQ	CQ	Duverseau YT, Magloire R, et al., 1986 [6]
1982	19	Port-au-Prince	CQ	Secondary	VT & VV CQ	N/A	Magloire R and Nguyen-dinh P, 1983 [18]
1982	18	Port-au-Prince	P & S/P	Primary	VT & VV P	VV S/P	Nguyen-Dinh P, Zevallos-Ipenza A, et al., 1984 [19]
1985	22	Port-au-Prince	P & S/P	Primary	VT P	VV & VT S/P	Nguyen-Dinh P, Payne D, et al., 1985 [21]
1995	N/A	Country Wide	N/A	Primary	N/A	VV CQ	Drabick JJ, Gambel JM, et al., 1997 [26]
2006-2007	79	Artibonite Valley	CQ	Secondary	PCR CQ	N/A	Londono BL, Eisele TP, et al., 2009 [32]
2010-2011	49	Leogane	CQ	Primary	N/A	PCR CQ	Neuberger Zhong K, et al., 2012 [36]

Key: Chloroquine (CQ), pyrimethamine (P), chloroquine with pyrimethamine (CQ/P),sulfadoxine with pyrimethamine (S/P), in vivo susceptibility (VV), in vitro susceptibility (VT), DNA examined for mutations via polymerase chain reaction (PCR).

ISSN: 2052-3211